文献速递自身炎症与 IgG4 相关病

TNFRSF11A基因变异参与系统性自身炎症性疾病:12例病例系列

TNFRSF11A variants contribute to systemic autoinflammatory diseases: A case series of 12 patients.
PubMed 文献 · Semin Arthritis Rheum · 2024-07-02

在167例系统性自身炎症性疾病(SAID)患者中筛查26个相关基因,12例(7%)携带至少一个TNFRSF11A罕见变异,且均合并其他SAID相关基因变异,最常见为MEFV(6例)。临床表现为类似TNF受体相关周期性综合征(TRAPS)的自身炎症综合征,但仅1例确诊TRAPS,作者认为TNFRSF11A变异可能参与SAID表型表达,需进一步研究确认新的致病通路。

要点

  • 167例SAID患者中12例(7%)携带TNFRSF11A罕见变异,均合并其他SAID相关基因变异。
  • 最常见合并变异为MEFV(6例),其余包括TNFRSF1A、NOD2、NLRP3、NLRP7、MVK、IL36RN、RBCK1、PLCG2和PSMB8。
  • 发作中位持续9天,表现为高热(91%)、肌痛(75%)、乏力(67%)、浆膜炎(58%)、关节痛/关节炎(58%)、胃肠道受累(33%)和皮疹(25%),对糖皮质激素有反应。

核心结论

  • TNFRSF11A变异在7%的SAID患者中出现,且总是与其他SAID相关基因变异合并存在,参与形成类似TRAPS的自身炎症综合征。
  • 作者认为需要额外研究来确认新的致病性SAID通路。

研究设计与样本

  • 对167例SAID患者筛查26个相关基因,描述TNFRSF11A变异患病率及疾病表型表达的病例系列。

主要发现

  • 12例(7%)患者携带至少一个TNFRSF11A罕见变异,其中男性7例,发病年龄中位数38岁。
  • 所有患者均合并至少一个其他SAID相关基因变异,最常见为MEFV(6例),其余包括TNFRSF1A、NOD2、NLRP3、NLRP7、MVK、IL36RN、RBCK1、PLCG2和PSMB8。
  • SAID发作中位持续9天,表现为高热(91%)、肌痛(75%)、乏力(67%)、浆膜炎(58%)、关节痛/关节炎(58%)、胃肠道受累(33%)和皮疹(25%),对糖皮质激素有反应。
  • 最常见的初步临床诊断为TRAPS,但仅1例确诊;2例MEFV变异支持非典型家族性地中海热诊断,2例NOD2变异推测为Yao综合征。
  • 剩余7例存在非典型疾病且无法明确诊断,支持TNFRSF11A变异可能参与SAID表型表达。

关键数值与推荐

  • TNFRSF11A罕见变异在167例SAID患者中检出12例(7%)。
  • 12例患者均合并其他SAID相关基因变异,MEFV合并变异6例。
  • 发作中位持续9天,高热91%、肌痛75%、乏力67%、浆膜炎58%、关节痛/关节炎58%、胃肠道受累33%、皮疹25%。
  • 初步诊断TRAPS最常见,但仅1例确诊;2例诊断非典型家族性地中海热,2例推测Yao综合征,7例无法明确诊断。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者认为需要额外研究来确认新的致病性SAID通路。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Limited evidence suggests that variants in TNFRSF11A gene, encoding RANK, may contribute to systemic autoinflammatory disease (SAID). AIM/METHODS: To estimate the prevalence of TNFRSF11A variants in a cohort of patients with SAIDs screened for 26 related genes and describe the disease phenotypic expression. RESULTS: A total of 12 out of 167 patients, 7 males, aged (median) 38 years at disease onset, yielded at least one TNFRSF11A rare variant. All patients carried a coexisting variant in at least one other SAID-related gene, most frequently MEFV (6 patients), but also TNFRSF1A, NOD2, NLRP3, NLRP7, MVK, IL36RN, RBCK1, PLCG2 and PSMB8. SAID episodes lasting (median) 9 days manifested with high grade fever (91%), myalgias (75%), malaise (67%), serositis (58%), arthralgias/arthritis (58%), gastrointestinal involvement (33%), and rash (25%), and responded to corticosteroids. The most common initial clinical diagnosis was TNF-associated periodic fever syndrome (TRAPS), which was, however, confirmed, in only one patient. The emergence of MEFV variations supported the diagnosis of atypical Familial Mediterranean Fever in two cases, whereas the diagnosis of Yao syndrome was speculated in two patients with NOD2 variants. The presence of atypical disease and the inability of defining diagnosis in the remaining 7 patients, supported the possible involvement of TNFRSF11A variants in the phenotypic expression of SAIDs. CONCLUSION: TNFRSF11A variants, occurring in 7% of SAID patients always in combination with other SAID-related gene variants, contribute to the development of an autoinflammatory syndrome resembling to TRAPS. Additional studies to confirm novel pathogenic SAID pathways are clearly warranted.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Papatheodorou V, Gerodimos C, Dimitrakopoulos A, et al. TNFRSF11A variants contribute to systemic autoinflammatory diseases: A case series of 12 patients. Semin Arthritis Rheum. 2024. PMID: 39003954. doi:10.1016/j.semarthrit.2024.152505

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。